Redmile Group, LLC - Director, 10%+ Owner at FATE THERAPEUTICS INC

Insider Transactions and Holdings

Entity Type
Company
Role
Director, 10%+ Owner
Issuer Symbol
FATE on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Redmile Group, LLC since 12 Mar 2025

Holdings reported by Redmile Group, LLC for FATE THERAPEUTICS INC

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Class A Convertible Preferred Stock 2,755,086 $23,142,722 $8.40 20 Dec 2024 Indirect Common Stock
Common Stock 12,884,277 $21,645,585 $1.68 20 Dec 2024 Indirect
Cash-settled Swaps 502,769 $844,652 $1.68 20 Dec 2024 Indirect Common Stock
Stock Option (Right to Buy) 55,000 $109,200 $2.73 29 May 2025 Indirect Common Stock

Transactions reported by Redmile Group, LLC for FATE THERAPEUTICS INC

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.